Clinical Trial Update: Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing belatacept to tacrolimus in deceased donor renal transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)
• belatacept (belatacept)

Snippet

Sponsor: Columbia University | Conditions: Implant or Graft; Rejection | Phase 4 | Status: COMPLETED | Results posted: 2019-09-10